Lost in Translation - Moving Your Research to Clinical Trials
This webinar describes steps and considerations involved in translating research to the clinic.
In this webinar hosted by FierceBiotech and sponsored by STEMCELL Technologies, Dr. Adrian Gee from the Baylor College of Medicine and Dr. David McKenna from the University of Minnesota discuss the process of translating cell therapy research to the clinic. Learn how you can ease the transition of your preclinical research by considering regulatory requirements in the early stages, and how optimization, engineering processes, and other factors affect timelines and clinical trials.
Publish Date:
May 14, 2021
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Qualification of Ancillary/Raw Materials for Clinical Use
Publish Date: June 20, 2018 -
The Impact of Ancillary Materials on Your Translational Research
Publish Date: September 11, 2019 -
Determining the Potency & Stability of Hematopoietic Cells
Publish Date: April 29, 2020
Explore Our Products
-
ImmunoCult™-XF T Cell Expansion Medium
Serum-free and xeno-free medium for the expansion of human T cells -
Automated closed-system immunomagnetic cell isolation instrument -
Automated and standardized colony counting for the hematopoietic colony-forming unit (CFU) assay -
cGMP, animal origin-free, stabilized, feeder-free maintenance medium for human ES and iPS cells
